Intrathoracic versus cervical anastomosis after totally or hybrid minimally invasive transthoracic oesophagectomy for oesophageal cancer: cost-effectiveness analysis alongside the randomized ICAN trial
Authors:
- Eric MatthéeEMEric Matthée
- Sander UbelsSUSander Ubels
- Bastiaan KlarenbeekBKBastiaan Klarenbeek
- Moniek H P VerstegenMVMoniek H P Verstegen
- Camiel RosmanCRCamiel Rosman
- ICAN Collaborative Research GroupIGICAN Collaborative Research Group
- Mark I van Berge HenegouwenMHMark I van Berge Henegouwen
- Freek DaamsFDFreek Daams
- Wietse EshuisWEWietse Eshuis
Open Access
- 7 May 2025
- journal article
- research article
- Published by Oxford University Press (OUP) in BJS Open
- Vol. 9 (3)
Abstract
Background: There is a worldwide trend towards minimally invasive oesophagectomy with intrathoracic anastomosis in oesophageal cancer surgery. Minimally invasive oesophagectomy with intrathoracic anastomosis has been shown to result in fewer anastomotic leaks, but cost-effectiveness is yet to be established. The aim of this study was to determine the cost-effectiveness of transthoracic minimally invasive oesophagectomy with intrathoracic anastomosis compared with cervical anastomosis. Methods: A prospective economic evaluation was performed alongside the ICAN trial, a randomized clinical superiority trial. Patients with mid/distal oesophageal or gastro-oesophageal junction cancer were randomly assigned to transthoracic minimally invasive oesophagectomy with either intrathoracic or cervical anastomosis. Quality-adjusted life-years, mean healthcare, and societal costs were assessed for both groups at 9 and 21 months after surgery. Results: A total of 245 patients randomized for transthoracic minimally invasive oesophagectomy with either intrathoracic (122) or cervical (123) anastomosis were included in the cost-effectiveness analysis. After 9 months, the intrathoracic group yielded 0.58 (95% confidence interval (c.i.) 0.55 to 0.61) quality-adjusted life-years per patient, compared with 0.56 (0.52 to 0.58) quality-adjusted life-years for the cervical group. After 9 months, both mean healthcare costs (20 573 (95% c.i. 17 623 to 24 177) versus 28 039 (23 574 to 33 116) euros), and societal costs (24 590 (21 237 to 29 074) versus 33 383 (27 885 to 38 805) euros), per patient were lower in the intrathoracic anastomosis group. Similarly, at 21 months no statistically significant difference was found (mean difference 0.08 (−0.05 to 0.2) quality-adjusted life-years), whereas minimally invasive oesophagectomy with intrathoracic anastomosis was less costly than that with cervical anastomosis (mean difference −9930 (−16 301 to −2521) euros). The higher costs in the cervical anastomosis group were mainly due to longer lengths of stay owing to complications. Conclusion: Transthoracic minimally invasive oesophagectomy with intrathoracic anastomosis was found to be cost-effective compared with transthoracic minimally invasive oesophagectomy with cervical anastomosis.Keywords
Funding Information
- The Netherlands Organization for Health Research Development Health Care Efficiency Research programme (843002607)
- ICAN
This publication has 30 references indexed in Scilit:
- Intrathoracic versus Cervical ANastomosis after minimally invasive esophagectomy for esophageal cancer: study protocol of the ICAN randomized controlled trialTrials, 2016
- Dutch Tariff for the Five-Level Version of EQ-5DValue in Health, 2016
- Worldwide trends in surgical techniques in the treatment of esophageal and gastroesophageal junction cancerDiseases of the Esophagus, 2016
- Management and outcome of cervical versus intrathoracic manifestation of cervical anastomotic leakage after transthoracic esophagectomy for cancerDiseases of the Esophagus, 2016
- Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force ReportValue in Health, 2015
- Cost-Effectiveness of Minimally Invasive Versus Open Esophagectomy for Esophageal CancerAnnals of Surgical Oncology, 2013
- Preoperative Chemoradiotherapy for Esophageal or Junctional CancerNew England Journal of Medicine, 2012
- Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)Quality of Life Research, 2011
- Cervical or Thoracic Anastomosis after Esophagectomy for Cancer: A Systematic Review and Meta-AnalysisDigestive Surgery, 2011
- Extended Transthoracic Resection Compared with Limited Transhiatal Resection for Adenocarcinoma of the EsophagusNew England Journal of Medicine, 2002